Key Takeaways
- • KKR is in advanced talks to acquire a majority stake in Medicover's India hospital operations for at least $1 billion, marking a significant expansion of the private equity firm's healthcare portfolio in India.
- • Medicover, the Stockholm-listed Swedish healthcare operator, owns 66.9% of Medicover Hospitals India and is seeking to sell its entire stake; KKR is simultaneously negotiating with minority shareholders to acquire their holdings.
- • Medicover Hospitals India operates 26 hospitals with approximately 6,000 beds across the country and entered the Indian market in 2016; the company has been preparing for a potential IPO alongside the sale discussions.
- • A non-binding agreement has been reached between the parties, though discussions remain ongoing with no certainty of transaction completion, and Medicover stated it will continue pursuing its IPO process in parallel.
- • KKR has been systematically increasing healthcare investments in India as part of a broader strategy to capitalize on growth in the world's most populous nation's healthcare sector.
Summary
KKR is pursuing a majority stake in Medicover Hospitals India through advanced negotiations valued at a minimum of $1 billion, according to a source with direct knowledge of the transaction. The deal would represent a substantial healthcare investment for KKR in India's rapidly expanding medical services market. Medicover, the Sweden-based parent company listed on the Stockholm exchange, disclosed the discussions in a press release on June 18, 2026, confirming that its Indian hospital arm is in negotiations with KKR regarding a potential sale of operations.
The Indian business represents a significant asset for acquisition. Medicover Hospitals India, in which Medicover holds a 66.9% controlling stake, operates a network of 26 hospitals with approximately 6,000 beds. The company established its presence in India in 2016 and has built a material footprint in the country's healthcare infrastructure. KKR's acquisition strategy encompasses acquiring Medicover's full controlling stake—valued at a minimum of $1.05 billion—while simultaneously engaging with minority shareholders to secure their holdings as part of achieving majority control.
The transaction remains preliminary but substantive. Discussions are described as ongoing with a non-binding agreement already in place, indicating the parties have moved beyond exploratory phases. However, Medicover emphasized in its statement that no certainty exists regarding transaction completion. The company is maintaining its parallel track to pursue an initial public offering of the Indian operations, preserving optionality until definitive terms are finalized.
This deal aligns with KKR's documented strategy of expanding healthcare exposure in India. The private equity firm has been steadily increasing its healthcare investments across the country, positioning itself to benefit from demographic trends and rising healthcare consumption in the world's most populous nation. The transaction, if completed, would constitute one of KKR's largest healthcare commitments in the Indian market to date.
The Indian business represents a significant asset for acquisition. Medicover Hospitals India, in which Medicover holds a 66.9% controlling stake, operates a network of 26 hospitals with approximately 6,000 beds. The company established its presence in India in 2016 and has built a material footprint in the country's healthcare infrastructure. KKR's acquisition strategy encompasses acquiring Medicover's full controlling stake—valued at a minimum of $1.05 billion—while simultaneously engaging with minority shareholders to secure their holdings as part of achieving majority control.
The transaction remains preliminary but substantive. Discussions are described as ongoing with a non-binding agreement already in place, indicating the parties have moved beyond exploratory phases. However, Medicover emphasized in its statement that no certainty exists regarding transaction completion. The company is maintaining its parallel track to pursue an initial public offering of the Indian operations, preserving optionality until definitive terms are finalized.
This deal aligns with KKR's documented strategy of expanding healthcare exposure in India. The private equity firm has been steadily increasing its healthcare investments across the country, positioning itself to benefit from demographic trends and rising healthcare consumption in the world's most populous nation. The transaction, if completed, would constitute one of KKR's largest healthcare commitments in the Indian market to date.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.